DAB Eesti OÜ

Year	Period	Submitted	Status
2025	01.01.2025 – 31.12.2025	31.03.2026	Valid	PDF
2024	01.01.2024 – 31.12.2024	31.03.2025	Valid	PDF
2023	01.01.2023 – 31.12.2023	26.03.2024	Valid	PDF
2022	01.01.2022 – 31.12.2022	20.03.2023	Valid	PDF
2021	01.01.2021 – 31.12.2021	29.05.2022	Valid	PDF
2020	01.01.2020 – 31.12.2020	19.03.2021	Valid	PDF
2019	01.01.2019 – 31.12.2019	31.03.2020	Valid	PDF
2018	01.01.2018 – 31.12.2018	29.03.2019	Valid	PDF
2017	01.01.2017 – 31.12.2017	02.04.2018	Valid	PDF
2016	01.01.2016 – 31.12.2016	17.03.2017	Valid	PDF
2015	01.01.2015 – 31.12.2015	01.04.2016	Valid	PDF
2014	01.01.2014 – 31.12.2014	17.03.2015	Valid	PDF
2013	01.01.2013 – 31.12.2013	31.03.2014	Valid	PDF
2012	01.01.2012 – 31.12.2012	21.06.2013	Valid	PDF
2011	01.01.2011 – 31.12.2011	26.04.2012	Valid	PDF
2010	01.01.2010 – 31.12.2010	27.04.2011	Valid	PDF
2009	01.01.2009 – 31.12.2009	03.06.2010	Valid	PDF
2008	01.01.2008 – 31.12.2008	03.12.2009	Valid	PDF
2008	01.01.2008 – 31.12.2008	16.07.2009	Expired	PDF
2007	01.01.2007 – 31.12.2007	21.07.2008	Valid	PDF
2006	01.01.2006 – 31.12.2006	04.05.2007	Valid	PDF
2005	27.06.2005 – 31.12.2005	14.07.2006	Valid	PDF

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 20.10.2026.

Check company creditworthiness in seconds

Detailed reviews of company financial risks and strengths

3€ /monthGet started

Tax debt Reports Declarations Court decisions3 Official announcements–TTJA decisions–Real estate–.ee domains1 Licenses1 Regulations26 Public transactions1158 Grants–State aid1 Public procurement40 Holdings in companies–Enforcement proceedings Payment orders

Tax data

Period	State taxes	Labour taxes	Taxable turnover	Employees
2026 Q3	71 572 €	26 158 €	439 662 €−21,2%	5
2026 Q2	91 721 €	27 455 €	558 247 €+5,8%	6
2026 Q1	90 317 €	32 349 €	527 735 €−10,3%	7
Total 2026:	253 610 €	85 962 €	1,53 M €
2025 Q4	102 512 €	30 129 €	588 208 €+47,3%	7
2025 Q3	69 955 €	26 515 €	399 258 €−25,9%	7
2025 Q2	91 304 €	30 924 €	538 549 €−18,1%	7
2025 Q1	89 520 €	24 502 €	657 318 €+3,7%	6
Total 2025:	353 291 €	112 070 €	2,18 M €
2024 Q4	93 634 €	21 395 €	633 777 €+34,8%	6
2024 Q3	67 218 €	20 908 €	470 182 €−27,7%	6
2024 Q2	117 196 €	24 571 €	650 669 €+7,0%	7
2024 Q1	88 555 €	27 634 €	607 832 €−27,4%	6
Total 2024:	366 603 €	94 508 €	2,36 M €
2023 Q4	118 112 €	27 098 €	837 049 €+2,0%	7
2023 Q3	105 179 €	26 526 €	820 503 €−15,7%	6
2023 Q2	156 704 €	27 931 €	973 137 €+10,9%	7
2023 Q1	109 449 €	27 038 €	877 401 €−11,3%	7
Total 2023:	489 444 €	108 593 €	3,51 M €
2022 Q4	125 017 €	23 623 €	989 183 €+12,2%	7
2022 Q3	105 796 €	21 866 €	881 502 €−22,2%	7
2022 Q2	157 646 €	24 271 €	1,13 M €+8,8%	5
2022 Q1	128 545 €	30 262 €	1,04 M €−7,3%	6
Total 2022:	517 004 €	100 022 €	4,04 M €
2021 Q4	125 293,86 €	23 388,97 €	1,12 M €+27,6%	8
2021 Q3	102 067,28 €	27 618,92 €	880 312,70 €−23,4%	7
2021 Q2	163 151,88 €	24 492,95 €	1,15 M €+9,4%	7
2021 Q1	116 319,88 €	26 133,64 €	1,05 M €−11,2%	7
Total 2021:	506 832,90 €	101 634,48 €	4,20 M €
2020 Q4	152 863,51 €	25 437,83 €	1,18 M €+14,4%	7
2020 Q3	167 035,59 €	17 474,89 €	1,03 M €+68,8%	6
2020 Q2	86 161,85 €	25 537,94 €	612 667,26 €−48,0%	6
2020 Q1	137 938 €	29 704 €	1,18 M €−6,3%	6
Total 2020:	543 998,95 €	98 154,66 €	4,01 M €
2019 Q4	142 393 €	24 370 €	1,26 M €+43,4%	6
2019 Q3	118 146 €	24 890 €	876 159 €−25,8%	7
2019 Q2	135 818 €	22 371 €	1,18 M €+11,9%	7
2019 Q1	132 797 €	30 081 €	1,05 M €−11,4%	8
Total 2019:	529 154 €	101 712 €	4,37 M €
2018 Q4	150 532 €	28 904 €	1,19 M €+29,2%	7
2018 Q3	124 540 €	35 118 €	921 289 €−23,7%	9
2018 Q2	186 418 €	29 878 €	1,21 M €+3,4%	9
2018 Q1	139 624 €	34 091 €	1,17 M €−13,0%	8
Total 2018:	601 114 €	127 991 €	4,49 M €
2017 Q4	163 724 €	23 758 €	1,34 M €+39,3%	9
2017 Q3	106 657 €	21 439 €	963 208 €+4,6%	9
2017 Q2	130 417 €	25 526 €	921 058 €−14,5%	6
2017 Q1	172 827 €	26 215 €	1,08 M €+75,6%	8
Total 2017:	573 625 €	96 938 €	4,30 M €
2016 Q4	143 644 €	21 872 €	613 838 €−4,3%	7
2016 Q3	106 785 €	22 865 €	641 702 €+11,7%	7
2016 Q2	165 773 €	20 472 €	574 525 €−22,1%	7
2016 Q1	112 356 €	26 270 €	737 247 €+23,2%	7
Total 2016:	528 558 €	91 479 €	2,57 M €
2015 Q4	126 649 €	19 752 €	598 284 €−2,9%	1
2015 Q3	85 965 €	20 340 €	616 093 €+11,6%	1
2015 Q2	130 676 €	18 226 €	552 061 €+0,3%	1
2015 Q1	101 682 €	18 167 €	550 301 €	1
Total 2015:	444 972 €	76 485 €	2,32 M €

Revenue by industry

	2023	2024	2025
Wholesale of pharmaceutical goods and medical supplies		1 433 751 €	1 308 305 €
Wholesale of pharmaceutical goods	2 140 629 €

Tax debts

No tax debt found

No tax debt as of 20.10.2026

Representatives

	Personal ID code
Beate Gaile	-	-	Board member	03.07.2026	-

17 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Shareholders

	Personal ID code
DAB Dental AB	-	-	Shareholder	95 931 EUR	100,00%	Sole ownership	01.09.2023	-

17 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Other persons

	Personal ID code
Claus Holmgaard	-	02.04.1966 (60)	Chairman of the supervisory board	31.07.2025	-
Frida Maria Agge	-	13.03.1982 (44)	Supervisory-board member	31.07.2025	-
Karl Jonas Redin	-	26.07.1982 (44)	Supervisory-board member	31.07.2025	-
Lauri Past	38306XXXXXX	20.06.1983 (43)	Audit firm	17.03.2017	-
Oksana Popova	48608XXXXXX	04.08.1986 (40)	Audit firm	17.03.2017	-

17 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Ultimate beneficial owners

	Personal ID code
Carl Reinhold Adolf Bennet	-	-	Indirect holding	02.10.2018	-

17 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Holdings in companies

No holdings in companies found

Company has no holdings in other companies

2026 Q3

Turnover

Amount: 439 662 €
Monthly average: 146 554 €
Per employee: 29 311 €
Equity ratio: 152,77%

Labour taxes

Turnover ratio: 5,95%
Tax ratio: 36,55%
Monthly average: 8 719 €
Per employee: 1 585 €

State taxes

Monthly average: 23 857 €
Turnover ratio: 16,28%

Estimated salary

Gross salary: 2 896 €
Net salary: 2 332 €

Aggregate data

Last 5 yrsAll

	2025	2024	2023	2022	2021	2020	2019
Current assets	916 536 €−14,6%	1 072 909 €−13,3%	1 237 267 €−1,5%	1 255 846 €+1,5%	1 236 937 €+2,9%	1 201 683 €−7,8%	1 303 389 €
Non-current assets	8 049 €−62,2%	21 295 €−41,0%	36 071 €−27,8%	49 938 €−31,5%	72 935 €+120%	33 099 €−25,1%	44 176 €
Total assets	924 585 €−15,5%	1 094 204 €−14,1%	1 273 338 €−2,5%	1 305 784 €−0,3%	1 309 872 €+6,1%	1 234 782 €−8,4%	1 347 565 €
Short-term liabilities	116 858 €+5,8%	110 456 €+2,9%	107 299 €−31,9%	157 538 €−14,4%	184 057 €+7,2%	171 627 €−31,7%	251 299 €
Long-term liabilities	-	-	-	-	-	-	-
Total liabilities	116 858 €+5,8%	110 456 €+2,9%	107 299 €−31,9%	157 538 €−14,4%	184 057 €+7,2%	171 627 €−31,7%	251 299 €
Share or stock capital	-	-	-	-	-	-	-
Retained earnings	398 288 €−4,4%	416 467 €+6,9%	389 751 €+7,8%	361 583 €+10,5%	327 372 €+8,9%	300 554 €	300 554 €
Net profit	-176 021 €−868%	-18 179 €−110%	190 828 €−5,2%	201 203 €−5,5%	212 983 €+20,2%	177 141 €−15,7%	210 252 €
Equity	807 727 €−17,9%	983 748 €−15,6%	1 166 039 €+1,5%	1 148 246 €+2,0%	1 125 815 €+5,9%	1 063 155 €−3,0%	1 096 266 €
Turnover	1 308 305 €−8,7%	1 433 751 €−33,0%	2 140 629 €−12,2%	2 437 723 €−4,9%	2 563 173 €−0,1%	2 564 500 €−8,7%	2 809 654 €
Profit margin	-13,5%	-1,3%	8,9%	8,3%	8,3%	6,9%	7,5%

Financial ratios

	2022	2021
Profit and cash flow
EBITDA	-	-
Liquidity
Current ratio	8,0	6,7
Quick ratio	5,1	4,4
Cash ratio	4,0	3,2
Efficiency
Days sales outstanding (dso)	30,0	29,9
Asset turnover	1,9	2,0
Structure
Debt ratio	0,1	0,1
Profitability
Operating margin	9,6%	9,4%
Net profit margin	8,3%	8,3%
Return on assets (roa)	15,4%	16,7%
Return on equity (roe)	17,5%	18,9%

Data export

These figures for over 281,000 companies, in one table

Revenue, EBITDA, ROE, ROA and other ratios
Up to five years of reports at once
Excel, CSV or JSON, updated daily

See how it works

To view all financial ratios, you need to subscribe to extended access to the info portal!

3€ /monthGet started

Licences & notices


Notice of economic activity	KHK013708	Commerce	Valid	12.12.2016	-

Regulations


Ä 10089703 / M6	03.07.2026	Directive order – Amendment entry	13.07.2026	Deficiencies remedied03.07.2026
Ä 10089703 / 17	03.07.2026	Entry – Amendment entry	-	Entered into force03.07.2026
Ä 10089703 / 16	29.08.2025	Entry – Amendment entry	-	Entered into force29.08.2025
Ä 10089703 / M5	18.06.2025	Order to remedy deficiencies – Amendment entry	04.07.2025	Deficiencies remedied28.08.2025
Ä 10089703 / 15	01.09.2023	Entry – Amendment entry	-	Entered into force01.09.2023

Real estate

No real estate found

Company has no real estate

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Court decisions


2-13-5159/71	Määruskaebusmenetlus	Court ruling	Law of obligations	Kaupo Paal, Ande Tänav, Reet Allikvere	ECLI:EE:TLRK:2015:2.13.5159.24929	21.10.2015	Open
3-2-1-16-15	Kassatsioonimenetlus	Court ruling	-	-	ECLI:EE:RK:2015:3.2.1.16.15.544	31.03.2015	Open
2-13-58562/30	Apellatsioonmenetlus	Court judgment	Labour law	Ande Tänav, Gaida Kivinurm, Iko Nõmm	ECLI:EE:TLRK:2015:2.13.58562.2739	22.01.2015	Open

Official announcements

No official announcements found

Company has no issued official announcements

Public transactions


23.09.2026	Kuressaare Haigla Sihtasutus	1 131,81 €Received	OPERATING EXPENSESDental services
17.09.2026	Sihtasutus Ida-Viru Keskhaigla	311,71 €Received	OPERATING EXPENSESGeneral hospital services
08.09.2026	Kuressaare Haigla Sihtasutus	220,08 €Received	OPERATING EXPENSESDental services
26.08.2026	aktsiaselts Valga Haigla	130,35 €Received	OPERATING EXPENSESGeneral hospital services
24.08.2026	Kuressaare Haigla Sihtasutus	1 105,79 €Received	OPERATING EXPENSESDental services

Funded projects

No funded projects found

The company has no projects funded by EU or foreign grants

State aid


01.04.2020	Tallinna LinnakantseleiAid measure 20912	KOMISJONI TEATIS Riigiabi ajutine raamistik majanduse toetamiseks praeguse COVID-19 puhangu kontekstis › Komisjoni teatise jaotis 3.1 "Otsetoetuste, tagasimakstvate ettemaksete või maksusoodustustena antav abi"Grant	0,02 €	20912/2000479

Public procurement contracts


06.03.2026End 23.03.2026	Reference number 306008 · MÜÜGILEPING	sihtasutus Tartu Ülikooli KliinikumContracting authority	1 385,20 €	Completed
04.02.2026	Reference number 304559 · MÜÜGILEPING	sihtasutus Tartu Ülikooli KliinikumContracting authority	232,40 €	Completed
21.05.2025End 25.05.2027	Reference number 288976 · MÜÜGILEPING nr 3-7/1901-1	Aktsiaselts Lääne-Tallinna KeskhaiglaContracting authority	24 000 €	Concluded
04.07.2024End 04.07.2026	Reference number 278135 · Raamleping 24	sihtasutus Tartu Ülikooli KliinikumContracting authority	26 862,86 €	Concluded
31.05.2024End 30.05.2025	Reference number 275917 · Dab Eesti OÜ_31.05.2025_hambatehniline labori materjal	Sihtasutus Tallinna HambakliinikContracting authority	124 866,68 €	Completed

.ee domains


opalescence-eesti.ee	Active	05.12.2025	06.12.2026

Enforcement proceedings

No enforcement proceedings found

Company has no active debts with bailiffs

Payment orders

No payment orders found

Company has no court-ordered payment orders

Data comes from public registers.